Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1352871

	registered interest
	date	06/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many covid-19 vaccines have been disposed of that were (a) out of date (b) unused to date.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	43653
	answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>The information requested is not currently centrally held. Work is ongoing across the vaccination programme to standardise and increase the information available for management purposes.</p><p>We have put in place robust mitigations throughout the vaccination programme to reduce wastage, manage expiry dates, and avoid vaccine destruction.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 11:00:27 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4658 label Biography information for Alex Sobel

1338069

	registered interest
	date	18/06/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Iron and Steel: Manufacturing Industries
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what his Department’s long-term plan is to support the creation of green jobs in the UK steel industry.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	18579
	answer	answer is ministerial correction date of answer 28/06/2021 answer text <p>Levelling up and ensuring high-quality employment across every region of the UK is a key element in the Government’s Plan for Growth. It is estimated that the UK low-carbon economy could grow more than four times faster than the rest of the economy between 2015 and 2030 and support up to 2 million jobs. The Government will ensure that the benefits of our growing low-carbon economy are shared fairly in every region.</p><p> </p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 28/06/2021 12:25:06 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4658 label Biography information for Alex Sobel

1338070

	registered interest
	date	18/06/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Iron and Steel: Manufacturing Industries
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment his Department has made of international progress on trials of hydrogen-based steelmaking; and if he will take steps to introduce a similar pilot in the UK.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	18580
	answer	answer is ministerial correction date of answer 28/06/2021 answer text <p>The UK is monitoring international progress on low carbon steel making trials, using hydrogen and other technologies, and is actively engaged in international initiatives to support industrial decarbonisation innovation, including the Mission Innovation platform and the Leadership Group for Industry Transition.</p><p> </p><p>Decarbonising UK industry is a core part of the government’s ambitious plan for the green industrial revolution. The Industrial Decarbonisation Strategy, published on 17 March, commits government to work with the Steel Council to consider the implications of the recommendation of the Climate Change Committee to ‘set targets for ore-based steelmaking to reach near-zero emissions by 2035’. The Steel Council offers the forum for government, industry and trade unions to work in partnership on the shared objective of creating an achievable, long-term plan to support the sector’s transition to a competitive, sustainable and low carbon future. Hydrogen-based steelmaking is one of the technological approaches being examined as part of this process.</p><p> </p><p>The UK steel sector will be given the opportunity to bid into industrial fuel switching innovation programmes under the £1 billion Net Zero Innovation Portfolio (NZIP), which is intended to promote switching away from more carbon-intensive fuel sources. The Government has also announced a £250 million Clean Steel Fund to support the UK steel sector to transition to lower carbon iron and steel production, through investment in new technologies and processes.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 28/06/2021 12:26:02 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4658 label Biography information for Alex Sobel

1338072

	registered interest
	date	18/06/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Clean Steel Fund
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, how his Department is planning to allocate the Clean Steel Fund; and when that allocation will be announced.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	18582
	answer	answer is ministerial correction date of answer 28/06/2021 answer text <p>The Department announced the Clean Steel Fund (CSF) in 2019 and it is currently in development. This policy will take time to design in order to be delivered effectively.</p><p> </p><p>Based on previous evidence, complex decarbonisation projects have long lead-in times and take time to set up. Due to this and other factors, the steel sector indicated in response to the 2019 Call for Evidence that their preference is for the CSF to be launched in 2023. Other schemes are available to support the sector and are live now, including the Industrial Energy Transformation Fund.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 28/06/2021 12:27:14 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4658 label Biography information for Alex Sobel

1338073

	registered interest
	date	18/06/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Iron and Steel: Carbon Emissions
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Education, whether his Department plans to commit to a 2035 target for near zero emissions in the steel sector in the Net Zero Strategy.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	18583
	answer	answer is ministerial correction date of answer 28/06/2021 answer text <p>The Industrial Decarbonisation Strategy, published on 17 March, commits to work with the newly constituted Steel Council to consider the implications of the recommendation of the Climate Change Committee to ‘set targets for ore-based steelmaking to reach near-zero emissions by 2035’. The Steel Council offers the forum for government, industry and trade unions to work in partnership on the shared objective of creating an achievable, long-term plan to support the sector’s transition to a competitive, sustainable and low carbon future.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 28/06/2021 12:28:19 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4658 label Biography information for Alex Sobel

1338087

	registered interest
	date	18/06/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Life Sciences
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, when he plans to publish his Department’s Life Sciences Strategy.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	18586
	answer	answer is ministerial correction date of answer 28/06/2021 answer text <p>The Office for Life Sciences are leading on the development of a Life Sciences Sector Vision, which is due to be published over the Summer.</p><p> </p><p>The Vision will form part of the HM Treasury Plan for Growth agenda, published at the Budget in March and will build on the successes of the 2017 Life Sciences Strategy, spearheaded by Sir John Bell.</p><p> </p><p>The Life Sciences Vision will be co-developed with industry and set out the Government’s ambitions for the Life Sciences sector over the next decade. It provides an opportunity to take into account the strengths of UK Life Sciences illustrated by COVID, put fresh energy behind the 2017 strategy themes, and identify new and emerging opportunities for the sector.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 28/06/2021 13:46:58 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4658 label Biography information for Alex Sobel

1338088

	registered interest
	date	18/06/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Life Sciences: Animal Experiments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps his Department is taking to ensure that increased life sciences sector activity and funding does not result in increased numbers of animal experiments.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	18587
	answer	answer is ministerial correction date of answer 28/06/2021 answer text <p>The Government believes that animals should only be used when there is no practicable alternative and it actively supports and funds the development and dissemination of techniques that replace, reduce and refine the use of animals in research (the 3Rs).  This is achieved primarily through funding for the National Centre for the 3Rs (NC3Rs), which works nationally and internationally to drive the uptake of 3Rs technologies and to ensure that advances in the 3Rs are reflected in policy, practice and regulations on animal research.  Since the NC3Rs was launched it has committed £100 million through its research, innovation, and early career awards to provide new 3Rs approaches for scientists in academia and industry to use.</p><p> </p><p>The NC3Rs is widely regarded as being world leading and has an ambitious international programme to reduce the use of animals in safety testing by working with regulators and companies from the pharmaceutical, chemical, agrochemical and consumer product sectors. This has led to changes in international regulations and company practices. Recent work includes the publication of the findings of a global data sharing project, led by the NC3Rs, that indicates that there are opportunities to shift to using one animal species rather than two for some chronic toxicity studies used in pharmaceutical drug evaluation.</p><p> </p><p>There has been a concern that increased life sciences activity resulting from research to find a treatment for the COVID-19 pandemic has resulted in increased use of animals in research. However, as detailed in the EU Clinical Trials Register (<a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.clinicaltrialsregister.eu%2F&amp;data=04%7C01%7CAmelia.Philpott%40officeforlifesciences.gov.uk%7Ca4b1b3b9d3d14d8a76cf08d8c77cd0ca%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637478686194820135%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=t91xmtUCkH%2F7eiVAbq05cr3F8eJ3VsZmOt%2FKbUN%2Fiqc%3D&amp;reserved=0" target="_blank">https://www.clinicaltrialsregister.eu/</a>) or Clinicaltrials.gov (<a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fclinicaltrials.gov%2F&amp;data=04%7C01%7CAmelia.Philpott%40officeforlifesciences.gov.uk%7Ca4b1b3b9d3d14d8a76cf08d8c77cd0ca%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637478686194820135%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=BXLCXusqUn%2F0fUQqeQ1acTF5E%2FyZerxgmD59479vw9Q%3D&amp;reserved=0" target="_blank">https://clinicaltrials.gov/</a>), the majority of products in these trials are “re-purposed” drugs and have already been developed for treatment of similar viral outbreaks, such as SARS and MERS, or have been used to treat acute respiratory distress syndrome or other inflammatory conditions. As such, none of these have required additional animal testing.</p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe. The rapid development of vaccines for COVID-19 has been based on a concept that the MHRA has long followed. Previous animal work on very similar vaccines have been used to support the development of the new vaccines and has reduced the number of animal studies.</p><p> </p><p>The MHRA work very closely with NC3Rs in bringing together stakeholders in academia, industry, government and animal welfare organisations to facilitate the exchange of information and ideas, and the translation of research findings into practice that benefits both animals and science.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 18590 question first answered 28/06/2021 13:48:53 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4658 label Biography information for Alex Sobel

1338090

	registered interest
	date	18/06/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Medicines and Diagnostics Manufacturing Transformation Fund
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, if his department will publish (a) the full criteria applied to applications for the Medicines and Diagnostics Manufacturing Transformation Fund and (b) an annual list of successful applicants to that fund.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	18589
	answer	answer is ministerial correction date of answer 28/06/2021 answer text <p>The full criteria applied to applications for the Medicines and Diagnostics Manufacturing Transformation Fund has been published and can be accessed via the following link: <a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fassets.publishing.service.gov.uk%2Fgovernment%2Fuploads%2Fsystem%2Fuploads%2Fattachment_data%2Ffile%2F988194%2Fmdmtf-medicines-diagnostics-manufacturing-transformation-fund-scheme-guidance.pdf&amp;data=04%7C01%7CLiam.Butler%40officeforlifesciences.gov.uk%7C3d57f2e2bd2f41fb2ceb08d93592e8b1%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637599727339691589%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=SVP6anB99LtFnuweT4U8f8MQ8gSKb77hMIVwIlb%2FKHA%3D&amp;reserved=0" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/988194/mdmtf-medicines-diagnostics-manufacturing-transformation-fund-scheme-guidance.pdf</a>.</p><p> </p><p>The fund runs only for a single year. We will ensure that the names of successful applicants to the fund are published in a timely manner.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 28/06/2021 13:44:34 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4658 label Biography information for Alex Sobel

1338091

	registered interest
	date	18/06/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Animal Experiments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, whether his Department has any plans to use the UK’s status as an independent nation outside the EU to set a global standard on actively phasing out animal testing.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	18590
	answer	answer is ministerial correction date of answer 28/06/2021 answer text <p>The Government believes that animals should only be used when there is no practicable alternative and it actively supports and funds the development and dissemination of techniques that replace, reduce and refine the use of animals in research (the 3Rs).  This is achieved primarily through funding for the National Centre for the 3Rs (NC3Rs), which works nationally and internationally to drive the uptake of 3Rs technologies and to ensure that advances in the 3Rs are reflected in policy, practice and regulations on animal research.  Since the NC3Rs was launched it has committed £100 million through its research, innovation, and early career awards to provide new 3Rs approaches for scientists in academia and industry to use.</p><p> </p><p>The NC3Rs is widely regarded as being world leading and has an ambitious international programme to reduce the use of animals in safety testing by working with regulators and companies from the pharmaceutical, chemical, agrochemical and consumer product sectors. This has led to changes in international regulations and company practices. Recent work includes the publication of the findings of a global data sharing project, led by the NC3Rs, that indicates that there are opportunities to shift to using one animal species rather than two for some chronic toxicity studies used in pharmaceutical drug evaluation.</p><p> </p><p>There has been a concern that increased life sciences activity resulting from research to find a treatment for the COVID-19 pandemic has resulted in increased use of animals in research. However, as detailed in the EU Clinical Trials Register (<a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.clinicaltrialsregister.eu%2F&amp;data=04%7C01%7CAmelia.Philpott%40officeforlifesciences.gov.uk%7Ca4b1b3b9d3d14d8a76cf08d8c77cd0ca%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637478686194820135%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=t91xmtUCkH%2F7eiVAbq05cr3F8eJ3VsZmOt%2FKbUN%2Fiqc%3D&amp;reserved=0" target="_blank">https://www.clinicaltrialsregister.eu/</a>) or Clinicaltrials.gov (<a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fclinicaltrials.gov%2F&amp;data=04%7C01%7CAmelia.Philpott%40officeforlifesciences.gov.uk%7Ca4b1b3b9d3d14d8a76cf08d8c77cd0ca%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637478686194820135%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=BXLCXusqUn%2F0fUQqeQ1acTF5E%2FyZerxgmD59479vw9Q%3D&amp;reserved=0" target="_blank">https://clinicaltrials.gov/</a>), the majority of products in these trials are “re-purposed” drugs and have already been developed for treatment of similar viral outbreaks, such as SARS and MERS, or have been used to treat acute respiratory distress syndrome or other inflammatory conditions. As such, none of these have required additional animal testing.</p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe. The rapid development of vaccines for COVID-19 has been based on a concept that the MHRA has long followed. Previous animal work on very similar vaccines have been used to support the development of the new vaccines and has reduced the number of animal studies.</p><p> </p><p>The MHRA work very closely with NC3Rs in bringing together stakeholders in academia, industry, government and animal welfare organisations to facilitate the exchange of information and ideas, and the translation of research findings into practice that benefits both animals and science.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 18587 question first answered 28/06/2021 13:48:53 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4658 label Biography information for Alex Sobel

1290086

	registered interest
	date	25/02/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of prioritising people with myalgic encephalomyelitis for covid-19 vaccinations.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	159021
	answer	answer is ministerial correction date of answer 05/03/2021 answer text <p>The Joint Committee on Vaccination and Immunisation has not identified any robust data to indicate that, as a group, persons with myalgic encephalomyelitis/chronic fatigue syndrome are at higher risk from COVID-19, therefore those under 50 years old with this condition are not prioritised for phase one of the programme.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 05/03/2021 13:53:39 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4658 label Biography information for Alex Sobel